Getting stroke patients
to the right hospital
for the right treatment
as fast as possible

TrianecT develops the next revolution in pre-hospital stroke care




The problem

Each year, 10 million severe stroke patients are picked up by ambulances around the world. Half of these stroke patients that can be treated with endovascular treatment, but are brought to hospitals that do not have endovascular treatment. This results in an average delay of endovascular treatment of 90 minutes, which leads to seriously worsened disease outcomes and a larger burden on society.

Our solution

With StrokePointer from TrianecT, we combine brain activity measurement and artificial intelligence to detect these treatable stroke patients in the ambulance and bring them directly to their best treatment. This saves time and time = brain.

Our Team

Dr. Wouter Potters

CEO, Co-founder

Dr. Jonathan Coutinho


Dr. Henk Marquering


Frank Zanow

Dr. Frank Zanow


Pascal Binnekamp

Algorithm developer

Simon van Bezooijen

Application developer

Amin Azouagh

Marketing Strategist 


apply now

Our partners

AMC Ventures Holding Logo


Amsterdam Science & Innovation Award


First clinical trial results


TrianecT incorporated

Do you want to join our mission to improve acute stroke care?

Then connect with us at


    Are you a talented and self-driven student looking for an internship? Do you want to take on a challenge  in our young and dynamic start-up? We welcome internship applications of excellent candidates (for example on marketing, sales, medical software development or UX design). Make sure to attach your curriculum vitae and your motivation letter when applying.

    Apply at